Monitor for updates on clinical trial progress and pipeline advancement; assess whether the capital deployment leads to value-accretive milestones. Watch for insider trading activity and future financing needs.
Price Chart
Executive Summary
Dianthus Therapeutics raised approximately $719 million in gross proceeds through a public offering of 8.47 million common shares and pre-funded warrants for 402,468 additional shares, priced at $81.00 per share. The capital will fund clinical development, commercial readiness, and general corporate purposes, extending the company's runway but increasing potential dilution for existing shareholders.
Key Financial Metrics
Key Facts
- Closed public offering of 8,470,989 common shares and pre-funded warrants for 402,468 shares
- Offering price: $81.00 per share; pre-funded warrants priced at $80.999 with $0.001 exercise price
- Aggregate gross proceeds: ~$719 million before expenses
- Proceeds to fund clinical and preclinical programs, commercial readiness, and general corporate use
- Joint book-runners include Jefferies, TD Cowen, Evercore ISI, Stifel, Guggenheim, and William Blair
Financial Impact
$719 million gross proceeds, significant capital raise with moderate dilution
Risk Factors
- Dilution to existing shareholders from new share issuance and potential warrant exercises
- Execution risk in clinical development and uncertain regulatory pathways for pipeline assets
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3255079 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▼ −8.12% | ▼ −6.22% | $89.96 (−19.97%) |
Aug 11, 2026 7w ago | Insider Cluster | $112.41 $103.28 | ▲ +8.12% | ▲ +6.22% | $89.96 (+19.97%) |
Aug 10, 2026 7w ago | 144 | $108.49 $107.04 | ▼ −1.34% | ▼ −0.28% | $89.96 (−17.08%) |
Jun 29, 2026 13w ago | Press Release | $95.68 $103.87 | ▲ +8.56% | ▲ +8.84% | $89.96 (−5.98%) |
Jun 12, 2026 16w ago | 8-K | $82.07 $97.60 | ▲ +18.92% | ▲ +17.14% | $89.96 (+9.61%) |
Jun 11, 2026 16w ago | Institutional Cluster | $76.45 $100.03 | ▲ +30.84% | ▲ +28.95% | $89.96 (+17.67%) |
May 5, 2026 21w ago | 8-K | $90.42 $84.97 | ▼ −6.03% | ▼ −8.81% | $89.96 (−0.51%) |
Mar 12, 2026 29w ago | Press Release | $77.86 $90.00 | ▲ +15.59% | ▲ +12.00% | $89.96 (+15.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access